http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105326815-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52 |
| filingDate | 2015-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105326815-B |
| titleOfInvention | The preparation method of Ambroxol albuterol controlled-release capsules |
| abstract | The invention relates to ambroxoxalbutamol controlled-release capsules, belonging to the field of pharmaceutical preparations. The poloxamer 188, meglumine and mannitol added in an appropriate amount to the controlled-release capsule of the present invention can significantly improve the stability and bioavailability of ambroxol hydrochloride and salbutamol sulfate in the preparation, with stable quality and remarkable effect. Effective treatment of respiratory diseases such as acute and chronic bronchitis and asthma. |
| priorityDate | 2015-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 52.